» Articles » PMID: 20085804

PGC-1alpha is Required for Training-induced Prevention of Age-associated Decline in Mitochondrial Enzymes in Mouse Skeletal Muscle

Overview
Journal Exp Gerontol
Specialty Geriatrics
Date 2010 Jan 21
PMID 20085804
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of the present study was to test the hypothesis that exercise training prevents an age-associated decline in skeletal muscle mitochondrial enzymes through a PGC-1alpha dependent mechanism. Whole body PGC-1alpha knock-out (KO) and littermate wildtype (WT) mice were submitted to long term running wheel exercise training or a sedentary lifestyle from 2 to 13 month of age. Furthermore, a group of approximately 4-month-old mice was used as young untrained controls. There was in both genotypes an age-associated approximately 30% decrease in citrate synthase (CS) activity and superoxide dismutase (SOD)2 protein content in 13-month-old untrained mice compared with young untrained mice. However, training prevented the age-associated decrease in CS activity and SOD2 protein content only in WT mice, but long term exercise training did increase HKII protein content in both genotypes. In addition, while CS activity and protein expression of cytc and SOD2 were 50-150% lower in skeletal muscle of PGC-1alpha mice than WT mice, the expression of the pro-apoptotic protein Bax and the anti-apoptotic Bcl2 was approximately 30% elevated in PGC-1alpha KO mice. In conclusion, the present findings indicate that PGC-1alpha is required for training-induced prevention of an age-associated decline in CS activity and SOD2 protein expression in skeletal muscle.

Citing Articles

Unraveling of Molecular Mechanisms of Cognitive Frailty in Chronic Kidney Disease: How Exercise Makes a Difference.

Michou V, Tsamos G, Vasdeki D, Deligiannis A, Kouidi E J Clin Med. 2024; 13(19).

PMID: 39407758 PMC: 11476541. DOI: 10.3390/jcm13195698.


Effects and potential mechanisms of exercise and physical activity on eye health and ocular diseases.

Zhang Q, Jiang Y, Deng C, Wang J Front Med (Lausanne). 2024; 11:1353624.

PMID: 38585147 PMC: 10995365. DOI: 10.3389/fmed.2024.1353624.


Mitochondrial bioenergetics: coupling of transport to tubular mitochondrial metabolism.

Cheng Y, Cheng C Curr Opin Nephrol Hypertens. 2024; 33(4):405-413.

PMID: 38573234 PMC: 11145760. DOI: 10.1097/MNH.0000000000000986.


Mitochondrial Quantity and Quality in Age-Related Sarcopenia.

Marzetti E, Calvani R, Coelho-Junior H, Landi F, Picca A Int J Mol Sci. 2024; 25(4).

PMID: 38396729 PMC: 10889427. DOI: 10.3390/ijms25042052.


Mitochondrial transplantation as a possible therapeutic option for sarcopenia.

Turkel I, Ozerklig B, Yilmaz M, Ulger O, Kubat G, Tuncer M J Mol Med (Berl). 2023; 101(6):645-669.

PMID: 37209146 DOI: 10.1007/s00109-023-02326-3.